Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

Description

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Conditions

Opioid Use Disorder, Serious Bacterial Infections

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With Opioid Use Disorder Hospitalized With Serious Injection-related Infection

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English-speaking adults aged 18 and above
  • * Any DSM-5 substance use disorder
  • * Can identify at least 2 individuals who can act as points of contact following discharge from the hospital
  • * Psychotic disorder, active suicidality, or homicidally
  • * Condition likely to be terminal during the study period
  • * Unable to perform consent due to impaired mental status

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Brigham and Women's Hospital,

Study Record Dates

2024-12